Clinical Trial Update: Phosphate Lowering in CKD Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial examining phosphate lowering in chronic kidney disease with cardiovascular disease has completed and results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Snippet

Sponsor: VA Office of Research and Development | Conditions: Chronic Kidney Disease, Cardiovascular Disease | Phase 4 | Status: COMPLETED | Results posted: 2022-08-26